Article Versions Notes

Laot L, Laas E, Girard N, Dumas E, Daoud E, Grandal B, Pierga J-Y, Coussy F, Kirova Y, El-Alam E, et al. The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes. Cancers. 2021; 13(2):171. https://doi.org/10.3390/cancers13020171

Laot, Lucie, Enora Laas, Noemie Girard, Elise Dumas, Eric Daoud, Beatriz Grandal, Jean-Yves Pierga, Florence Coussy, Youlia Kirova, Elsy El-Alam, and et al. 2021. "The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes" Cancers 13, no. 2: 171. https://doi.org/10.3390/cancers13020171

Laot, L., Laas, E., Girard, N., Dumas, E., Daoud, E., Grandal, B., Pierga, J.-Y., Coussy, F., Kirova, Y., El-Alam, E., Bataillon, G., Lae, M., Llouquet, F., Reyal, F., & Hamy, A.-S. (2021). The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes. Cancers, 13(2), 171. https://doi.org/10.3390/cancers13020171